Martinsville, NJ, United States of America

Lars Birgerson


Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 75(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Lars Birgerson: Innovator in Pharmacological Treatments

Introduction

Lars Birgerson is a notable inventor based in Martinsville, NJ (US), recognized for his contributions to pharmacology. He holds 5 patents that focus on innovative treatments for various physiological and psychiatric conditions. His work has significantly impacted the field of medicine, particularly in the development of selective norepinephrine reuptake inhibitors.

Latest Patents

Birgerson's latest patents include "Highly selective norepinephrine reuptake inhibitors and methods of using the same." This patent discloses methods and compositions for treating humans suffering from, or preventing a human from suffering, a physiological or psychiatric disease, disorder, or condition where inhibiting the reuptake of norepinephrine is beneficial. The compositions comprise a compound with a pharmacological selectivity of serotonin (K)/norepinephrine (K) of at least about 5000. Examples of such compounds include reboxetine, particularly the optically pure (S,S) enantiomer of reboxetine. The methods generally involve administering a therapeutic amount of these compositions. Additionally, he has developed a "Method of treating chronic fatigue syndrome," which includes administering a therapeutic amount of racemic reboxetine or a pharmaceutically acceptable salt thereof to individuals suffering from this condition.

Career Highlights

Throughout his career, Lars Birgerson has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn Company and Pfizer Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Birgerson has collaborated with notable professionals in his field, including Erik H F Wong and Saeeduddin Ahmed. These collaborations have further enhanced his research and development efforts in pharmacological treatments.

Conclusion

Lars Birgerson's innovative work in pharmacology, particularly in the development of norepinephrine reuptake inhibitors, showcases his significant contributions to medical science. His patents and collaborations reflect a commitment to improving treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…